Biotech firms jump on SARS bandwagon.
作者信息
Basu Paroma
出版信息
Nat Biotechnol. 2003 Jul;21(7):720. doi: 10.1038/nbt0703-720a.
Abstract
摘要
相似文献
1
Biotech firms jump on SARS bandwagon.
Nat Biotechnol. 2003 Jul;21(7):720. doi: 10.1038/nbt0703-720a.
2
Benefits of biotech clusters questioned.
Nat Biotechnol. 2003 Nov;21(11):1258-9. doi: 10.1038/nbt902.
3
Michigan's next wave of biopharmaceutical entrepreneurship.
Nat Biotechnol. 2003 Sep;21(9):1109-11. doi: 10.1038/nbt0903-1109.
4
Biotech parks proliferate, despite concerns over sustainability.
Nat Biotechnol. 2003 Nov;21(11):1259-60. doi: 10.1038/nbt900.
5
China spurs pharma innovation.
Nat Rev Drug Discov. 2010 Aug;9(8):581-2. doi: 10.1038/nrd3238.
6
Taiwan: Biotech vision.
Nat Biotechnol. 2003 Apr;21(4):463-4. doi: 10.1038/nbt0403-463.
7
UK biotech sector loses flagship PowderJect to Chiron.
Nat Biotechnol. 2003 Jul;21(7):717. doi: 10.1038/nbt0703-717.
8
Biotechnology in Ireland: hard work, money and the brain gain.
Drug Discov Today. 2007 Feb;12(3-4):108-11. doi: 10.1016/j.drudis.2006.11.014. Epub 2006 Dec 5.
9
Biotech R&D still reeling.
Nat Biotechnol. 2004 Sep;22(9):1068. doi: 10.1038/nbt0904-1068.
10
China's biotech experiments.
Nat Biotechnol. 2005 Dec;23(12):1472-3. doi: 10.1038/bioent884.
引用本文的文献
1
"Teaching old drugs to kill new bugs": structure-based discovery of anti-SARS drugs.
Biochem Biophys Res Commun. 2004 Aug 20;321(2):370-8. doi: 10.1016/j.bbrc.2004.06.155.
Zotero 插件